The Single-Cell Proteomics Blog

Industry pioneers' backed data straight to your inbox.

Grant Challenge Winners
,
February 26, 2021
Announcing the Recipients of the Single-Cell Proteomics Grant Challenge
Read More
,
February 22, 2021
Webinar Now Available: Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology with Dr. James Heath
Read More
February 12, 2021
Upcoming Event: Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
Read More
February 9, 2021
IsoPlexis’ Next Generation Biomarkers Predict Neurotoxicity in CAR-T Therapy
Read More
February 4, 2021
IsoPlexis’ Functional Single-Cell Proteomics Identifies Key Drivers of Transplant Rejection: Published in American Journal of Transplantation
Read More
January 21, 2021
How Single-Cell Proteomics Adds New Data Layers to Our Understanding of The Adaptive Immune Response
Read More
January 12, 2021
IsoPlexis’ IsoSpark Wins 2021 BIG Innovation Award
Read More
,
January 9, 2021
Recent Highlights: IsoPlexis Driving the Convergence of Dynamic Proteomics and Single-Cell Biology
Read More
Phenovista
December 22, 2020
IsoPlexis & PhenoVista Biosciences Partner to Provide Access to a Comprehensive Range of Cellular Assay Technologies
Read More
, ,
December 18, 2020
IsoU E-Learning Series: Reducing Hands-On Experimental Time & Obtaining Quality Insights Faster with IsoPlexis’ Highly Multiplexed, Walk-Away Proteomics
Read More
E-Learning Series: Resolving Cancer Resistance and Metastasis with IsoPlexis’ Award-Winning Intracellular Signaling Omi
,
December 11, 2020
IsoU E-Learning Series: Resolving Cancer Resistance and Metastasis with IsoPlexis’ Award Winning Intracellular Signaling Omics Solution
Read More
Upcoming Event
,
December 3, 2020
Upcoming Event: Accelerating Immune Medicine with IsoPlexis’ Walk-Away High-Plex Proteomics
Read More
upcoming event
November 24, 2020
Upcoming Event: Accelerating Targeted Therapies with IsoPlexis’ Intracellular Signaling Omics
Read More
Isospark
,
November 16, 2020
Spark the Next Big Breakthroughs in Personalized Immune Medicine with IsoPlexis’ Walk-Away Proteomics Systems
Read More
November 11, 2020
IsoPlexis’ Blood-Based Biomarker Predicts Progression-Free Survival in Melanoma Study
Read More
,
November 9, 2020
Launch Events this Week: How Harnessing Our Most Powerful Cells is Changing Immune Medicine
Read More
Cell Stem Cell
November 5, 2020
Deeper Dive in Cell Stem Cell: Confirming Function of CRISPR-Edited Cells with IsoPlexis’ Functional Immune Landscaping
Read More
Cell
October 28, 2020
Publication in Cell: IsoPlexis’ Functional Proteomics Identifies Prognostic Biomarker of Inflammation in COVID-19
Read More
Product Launch
,
October 22, 2020
Product Launch: IsoPlexis’ High-Plex Automated Immunoassays Enable Fast Highly Multiplexed Proteomics for Accelerated Insights
Read More
Product Launch
,
October 20, 2020
Product Launch: IsoPlexis’ Intracellular Signaling Omics Characterizes Signaling Mechanisms Driving Resistance
Read More
,
October 15, 2020
IsoPlexis’ Functional Immune Landscaping Enables Critical Single-Cell Discoveries
Read More
Neuroinflammation App Note
October 1, 2020
App Note: IsoPlexis’ Functional Proteomics Reveals Unique Secretome Signatures & Insights into Neuroinflammation
Read More
,
September 23, 2020
Understanding the Mechanisms of Neurological Complications in COVID-19 with IsoPlexis’ Functional Proteomics
Read More
IsoPlexis Predicts Cancer Resistance
September 18, 2020
Cancer Resistance Timeline: How IsoPlexis’ Single-Cell Proteomics Can Predict Resistance and Enable Therapies to Combat Drug-Resistant Cell States
Read More
IsoSpeak Tour
September 10, 2020
New Interactive IsoSpeak Demo: Virtually Explore IsoPlexis’ End-to-End Software Suite for Same Day Insights
Read More
September 9, 2020
Roundtable Discussion Part 2: IsoPlexis’ Functional Proteomics Accelerates Innovations in Cancer Immunology Research
Read More
multiple COVID partnerships
September 2, 2020
Single-Cell Functional Proteomics from IsoPlexis is Powering Multiple High-Impact Partnerships on COVID-19
Read More
CCR Publication
August 28, 2020
IsoPlexis’ Single-Cell Functional Proteomics Enables Identification of Key Immune Biomarkers of COVID-19
Read More
Covid Challenge
, ,
August 25, 2020
Single-Cell Proteomics Grant Challenge: COVID-19
Read More
August 24, 2020
Publication in Clinical Cancer Research: IsoPlexis’ Single-Cell Proteomics Reveals Unique Cell Subsets Associated with Improved Outcomes in Triple Negative Breast Cancer
Read More
,
August 21, 2020
Publication in Frontiers in Immunology: IsoPlexis’ Highly Functional T Cells are Critical to Durable Vaccines
Read More
Lonza Webinar
, ,
August 17, 2020
IsoPlexis and Lonza Webinar Wrap-Up: The Future of Cellular Immunotherapies
Read More
August 12, 2020
IsoPlexis Selects FlowMetric Life Sciences, Inc. as a Certified Service Provider of IsoPlexis’ Unique Functional Proteomics
Read More
August 7, 2020
Upcoming Webinar with Lonza & IsoPlexis – The Future of Cellular Immunotherapy: Highly Automated Precision Medicine
Read More
August 7, 2020
IsoPlexis’ Single-Cell Proteomics Accelerates Nanoparticle Vaccine Development in Frontiers in Immunology Publication
Read More
Jon Chen
August 6, 2020
IsoPlexis’ Single-Cell Secretome Identifies Highly Polyfunctional Superhero Cells Predicting Clinical Outcomes
Read More
July 30, 2020
IsoPlexis Expands the IsoLight Platform to the Chinese Life Science Market Through Partnership with Neoline
Read More
IsoLight Virtual Demo
July 29, 2020
IsoPlexis’ Virtual Tour Now Available
Read More
cancer Immunology Roundtable
July 24, 2020
Roundtable Discussion: IsoPlexis’ Single-Cell Proteomics Accelerates Innovations in Cancer Immunology Research
Read More
Arold Levine
July 22, 2020
Dr. Arnold Levine Webinar: The Structure and Functions of the p53 Pathway
Read More
July 21, 2020
Webinar Now Available: Improving COVID-19 Treatment & Vaccine Development with Single-Cell Proteomics
Read More
July 16, 2020
IsoPlexis’ Unique Single-Cell Proteomics Accelerates CRISPR-Engineered NK Cell Therapy to Predict Enhanced Anti-Tumor Activity & Persistence
Read More
biocompare
July 15, 2020
Life Sciences Guide, Biocompare, Highlights Critical Nature of IsoPlexis’ Single-Cell Proteomics for COVID-19 Immune Monitoring
Read More
Super-villain Cells
, ,
July 8, 2020
Polyfunctional Cells are the Subsets with “Superpowers”: Case Studies Part 2
Read More
Superhero cells
, ,
July 2, 2020
Polyfunctional Cells are the Subsets with “Superpowers”: Part 1
Read More
Jim Heath Webinar
June 25, 2020
Upcoming Webinar – Jim Heath, President of the ISB, on Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics
Read More
Arnold Levine p53 Webinar
June 24, 2020
Upcoming Webinar – Arnold Levine, Discoverer of p53 on the Structure and Functions of the p53 Pathway: Information Acquisition, Redundancy, and Connectivity
Read More
Plasma CSF
,
June 19, 2020
COVID-19 Publication: Uncovering Cytokines Driving Neuroinflammation in COVID-19 Patients with IsoPlexis’ Unique Functional Proteomics
Read More
COVID as Blood Vessel Disease
June 16, 2020
COVID-19 May Be a Blood Vessel Disease: Why This is Important & How IsoPlexis’ Unique Functional Proteomics Can Provide Insight into Endothelial Inflammation
Read More
Shelli Farhadian
,
June 10, 2020
Understanding the Role of Cytokines and Neuroinflammation in COVID-19 Patients with Neurological Manifestations: Interview with Shelli Farhadian
Read More

Categories

Resources

Further Learning

Follow the Data.
Your Data is Secure

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

Stay informed in just 5 minutes. Get the weekly email to keep you at the forefront of single-cell & multiplexed proteomics.